Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Immunoblastic Lymphadenopathy × tanespimycin × Clear all

Sponsor

Conditions

von Hippel-Lindau Disease 1 Thyroid Neoplasms 1 Thyroid Cancer, Papillary 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large-Cell, Anaplastic 1 Kidney Neoplasms 1 Hodgkin Disease 1 Carcinoma, Renal Cell 1 Carcinoma, Medullary 1 Breast Neoplasms 1 Adenocarcinoma, Follicular 1

Interventions

fludarabine phosphate 14 Cyclophosphamide 13 Whole-Body Irradiation 11 Peripheral Blood Stem Cell Transplantation 11 Etoposide 10 Tacrolimus 9 Mycophenolic Acid 7 Rituximab 6 Methotrexate 6 Melphalan 6 Cyclosporine 6 Busulfan 6 Antilymphocyte Serum 6 Vorinostat 4 Sirolimus 4 Prednisone 4 Lenalidomide 4 Immunohistochemistry 4 Gene Expression Profiling 4 Carboplatin 4 Vincristine 3 Microarray Analysis 3 Everolimus 3 Doxorubicin 3 Dexamethasone 3 Alemtuzumab 3 thymoglobulin 2 prednylidene 2 fludarabine 2 etoposide phosphate 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡